Loading [MathJax]/jax/output/SVG/jax.js
Mini review Topical Sections

The essential measures to improve the management of anaphylaxis

  • Received: 03 August 2020 Accepted: 02 November 2020 Published: 04 November 2020
  • Studies of anaphylaxis in humans is scarce. It has been proven that the frequency of anaphylactic reactions is in increase and its management is not adequate and/or below an acceptable level. The prescription of auto-injectable epinephrine for use outside the hospital, which is the treatment of choice for an anaphylactic reaction, and its correct administration is drastically low. The proper management of anaphylaxis involves improving the training of patient's behaviors to allow both (i) prevention (avoiding known triggers of anaphylaxis) and (ii) effective treatment (adherence to a self-care plan and training to apply epinephrine with an auto-injector). Therefore, it is necessary to ensure and monitor the correct prescription of adrenaline auto-injectors as well as the training of health professionals in such use.

    Citation: Fernando-Miguel Gamboa-Antiñolo. The essential measures to improve the management of anaphylaxis[J]. AIMS Medical Science, 2020, 7(4): 293-297. doi: 10.3934/medsci.2020018

    Related Papers:

    [1] Jinguo Zhang, Shuhai Zhu . On criticality coupled sub-Laplacian systems with Hardy type potentials on Stratified Lie groups. Communications in Analysis and Mechanics, 2023, 15(2): 70-90. doi: 10.3934/cam.2023005
    [2] Xueqi Sun, Yongqiang Fu, Sihua Liang . Normalized solutions for pseudo-relativistic Schrödinger equations. Communications in Analysis and Mechanics, 2024, 16(1): 217-236. doi: 10.3934/cam.2024010
    [3] Yuxuan Chen . Global dynamical behavior of solutions for finite degenerate fourth-order parabolic equations with mean curvature nonlinearity. Communications in Analysis and Mechanics, 2023, 15(4): 658-694. doi: 10.3934/cam.2023033
    [4] Lovelesh Sharma . Brezis Nirenberg type results for local non-local problems under mixed boundary conditions. Communications in Analysis and Mechanics, 2024, 16(4): 872-895. doi: 10.3934/cam.2024038
    [5] Leandro Tavares . Solutions for a class of problems driven by an anisotropic $ (p, q) $-Laplacian type operator. Communications in Analysis and Mechanics, 2023, 15(3): 533-550. doi: 10.3934/cam.2023026
    [6] Eleonora Amoroso, Angela Sciammetta, Patrick Winkert . Anisotropic $ (\vec{p}, \vec{q}) $-Laplacian problems with superlinear nonlinearities. Communications in Analysis and Mechanics, 2024, 16(1): 1-23. doi: 10.3934/cam.2024001
    [7] Huiting He, Mohamed Ousbika, Zakaria El Allali, Jiabin Zuo . Non-trivial solutions for a partial discrete Dirichlet nonlinear problem with $ p $-Laplacian. Communications in Analysis and Mechanics, 2023, 15(4): 598-610. doi: 10.3934/cam.2023030
    [8] Velimir Jurdjevic . Time optimal problems on Lie groups and applications to quantum control. Communications in Analysis and Mechanics, 2024, 16(2): 345-387. doi: 10.3934/cam.2024017
    [9] Qi Li, Yuzhu Han, Bin Guo . A critical Kirchhoff problem with a logarithmic type perturbation in high dimension. Communications in Analysis and Mechanics, 2024, 16(3): 578-598. doi: 10.3934/cam.2024027
    [10] Jonas Schnitzer . No-go theorems for $ r $-matrices in symplectic geometry. Communications in Analysis and Mechanics, 2024, 16(3): 448-456. doi: 10.3934/cam.2024021
  • Studies of anaphylaxis in humans is scarce. It has been proven that the frequency of anaphylactic reactions is in increase and its management is not adequate and/or below an acceptable level. The prescription of auto-injectable epinephrine for use outside the hospital, which is the treatment of choice for an anaphylactic reaction, and its correct administration is drastically low. The proper management of anaphylaxis involves improving the training of patient's behaviors to allow both (i) prevention (avoiding known triggers of anaphylaxis) and (ii) effective treatment (adherence to a self-care plan and training to apply epinephrine with an auto-injector). Therefore, it is necessary to ensure and monitor the correct prescription of adrenaline auto-injectors as well as the training of health professionals in such use.


    A mapping f:UV is called additive if f satisfies the Cauchy functional equation

    f(x+y)=f(x)+f(y) (1.1)

    for all x,yU. It is easy to see that the additive function f(x)=ax is a solution of the functional equation (1.1) and every solution of the functional equation (1.1) is said to be an additive mapping. A mapping f:UV is called quadratic if f satisfies the quadratic functional equation

    f(x+y)+f(xy)=2f(x)+2f(y) (1.2)

    for all x,yU. A mapping f:UV is quadratic if and only if there exist a symmetric biadditive mapping B:U2V such that f(x)=B(x,x) and this B is unique, refer (see [1,10]). It is easy to see that the quadratic function f(x)=ax2 is a solution of the functional equation (1.2) and every solution of the functional equation (1.2) is said to be a quadratic mapping.

    Mixed type functional equation is an advanced development in the field of functional equations. A single functional equation has more than one nature is known as mixed type functional equation. Further, in the development of mixed type functional equations, atmost only few functional equations have been obtained by many researchers (see [3,6,9,11,12,16,17,22,24]).

    Let G be a group and H be a metric group with a metric d(.,.). Given ϵ>0 does there exists a δ>0 such that if a function f:GH satisfies d(f(xy),f(x)f(y))<δ for all x,yG, then is there exist a homomorphism a:GH with d(f(x),a(x))<ϵ for all xG? This problem for the stability of functional equations was raised by Ulam [23] and answerd by Hyers [7]. Later, it was developed by Rassias [20], Rassias [18,21] and Gvuruta [5].

    The probabilistic modular space was introduced by Nourouzi [14] in 2007. Later, it was developed by K. Nourouzi [4,15].

    Definition 1.1. Let V be a real vector space. If μ:VΔ fulfills the following conditions

    (ⅰ) μ(v)(0)=0,

    (ⅱ) μ(v)(t)=1 for all t>0, if and only if v=γ (γ is the null vector in V),

    (ⅲ) μ(v)(t)=μ(v)(t),

    (ⅳ) μ(au+bv)(r+t)μ(v)(r)μ(v)(t)

    for all u,vV, a,b,r,tR+, a+b=1, then a pair (V,μ) is called a probabilistic modular space and (V,μ) is b-homogeneous if ρ(av)(t)=μ(v)(t|a|b) for all vV,t>0, aR{0}. Here Δ is g:RR+ the set of all nondecreasing functions with inftRg(t)=0 and suptRg(t)=1. Also, the function min is denoted by .

    Example 1.2. Let V be a real vector space and μ be a modular on X. Then a pair (V,μ) is a probabilistic modular space, where

    μ(v)(t)={tt+ρ(x),t>0,vV0,t0,vV.

    In 2002, Rassias [19] studied the Ulam stability of a mixed-type functional equation

    g(3i=1xi)+3i=1g(xi)=1ij3g(xi+xj).

    Later, Nakmalachalasint [13] generalized the above functional equation and obtained an n-variable mixed-type functional equation of the form

    g(ni=1xi)+(n2)ni=1g(xi)=1ijng(xi+xj)

    for n>2 and investigated its Ulam stability.

    In 2005, Jun and Kim [8] introduced a generalized AQ-functional equation of the form

    g(x+ay)+ag(xy)=g(xay)+ag(x+y)

    for a0,±1.

    In 2013, Zolfaghari et al. [25] investigated the Ulam stability of a mixed type functional equation in probabilistic modular spaces. In the same year, Cho et al. [2] introduced a fixed point method to prove the Ulam stability of AQC-functional equations in β-homogeneous probabilistic modular spaces.

    Motivated from the notion of probabilistic modular spaces and by the mixed type functional equations, we introduce a new mixed type functional equation satisfied by the solution f(x)=x+x2 of the form

    n1i=1,j=i+1(f(2xi+xj))+f(2xn+x1)2[n1i=1,j=i+1(f(xi+xj))+f(xn+x1)]=ni=1f(xi), (1.3)

    for nN and investigate its Ulam stability in probabilistic modular spaces.

    This paper is organized as follows: In Section 1, we provide a necessary introduction of this paper. In Sections 2 and 3, we obtain the general solution of the functional equation (1.3) in even case and in odd case, respectively. In Sections 4 and 5, we investigate the Ulam stability of (1.3) in probabilistic modular space by using fixed point theory for even and odd cases, respectively and the conclusion is given in Section 6.

    Let U and V be real vector spaces. In this section, we obtain the general solution of a mixed type functional equation (1.3) for even case of the form

    n1i=1,j=i+1(f(2xi+xj))+f(2xn+x1)2[n1i=1,j=i+1(f(xi+xj))+f(xn+x1)]=ni=1f(xi) (2.1)

    for nN.

    Theorem 2.1. Let f:UV satisfy the functional equation (2.1). If f is an even mapping, then f is quadratic.

    Proof. Assume that f:UV is even and satisfies the functional equation (2.1). Replacing (x1,x2,,xn) by (0,0,,0) and by (x1,0,,0) in (2.1), we obtain f(0)=0 and

    f(2x1)=4f(x1) (2.2)

    for all x1U, respectively. Again, replacing (x1,x2,x3,,xn) by (x1,x1,0,,0) in (2.1), we have

    f(3x1)=9f(x1) (2.3)

    for all x1U. Now, from (2.2) and (2.3), we get

    f(nx1)=n2f(x1),

    for all x1U. Replacing (x1,x2,x3,x4,,xn) by (x1,x2,x2,0,,0) in (2.1), we obtain

    f(2x1+x2)+f(x1+2x2)=4f(x1+x2)+f(x1)+f(x2) (2.4)

    for all x1,x2U. Replacing (x1,x2,x3,x4,,xn) by (x1,x2,0,0,,0) in (2.1), we get

    f(2x1+x2)+f(x2)=2f(x1+x2)+2f(x1) (2.5)

    for all x1,x2U. Replacing x2 by x2 in (2.5), using the evenness of f and again adding the resultant to (2.5), we get

    f(2x1+x2)+f(2x1x2)+2f(x2)=2f(x1+x2)+2f(x1x2)+4f(x1) (2.6)

    for all x1,x2U. Replacing (x1,x2) by (x1+x2,x1x2) in (2.6), we get

    f(3x1+x2)+f(x1+3x2)=4f(x1+x2)2f(x1x2)+8f(x1)+8f(x2) (2.7)

    for all x1,x2U. Letting (x1,x2) by (x1,x1+x2) in (2.5), we get

    f(3x1+x2)+f(x1+x2)=2f(2x1+x2)+2f(x1) (2.8)

    for all x1,x2U. Replacing x1 by x2 and x2 by x1 in (2.8), we have

    f(x1+3x2)+f(x1+x2)=2f(x1+2x2)+2f(x2) (2.9)

    for all x1,x2U. Now, adding (2.8) and (2.9), we obtain

    f(3x1+x2)+f(x1+3x2)+2f(x1+x2)=2f(2x1+x2)+2f(x1+2x2)+2f(x1)+2f(x2) (2.10)

    for all x1,x2U. Using (2.4), (2.7) and (2.10), we obtain (1.2). Hence the mapping f is quadratic.

    Let U and V be real vector spaces. In this section, we obtain the general solution of a mixed type functional equation (1.3) for even case of the form

    n1i=1,j=i+1(f(2xi+xj))+f(2xn+x1)2[n1i=1,j=i+1(f(xi+xj))+f(xn+x1)]=ni=1f(xi) (3.1)

    for nN.

    Theorem 3.1. Let f:UV satisfy the functional equation (3.1). If f is an odd mapping, then f is additive.

    Proof. Assume that f is odd and satisfies the functional equation (3.1). Replacing (x1,x2,,xn) by (0,0,,0) and (x1,0,,0) in (3.1), we obtain f(0)=0 and

    f(2x1)=2f(x1) (3.2)

    for all x1U, respectively. Again, replacing (x1,x2,x3,,xn) by (x1,x1,0,,0) in (3.1), we have

    f(3x1)=9f(x1) (3.3)

    for all x1U. Now, from (3.2) and (3.3), we get

    f(nx1)=nf(x1)

    for all x1U. Replacing (x1,x2,x3,x4,,xn) by (x1,x2,0,0,,0) in (3.1), we get

    f(2x1+x2)2f(x1+x2)=f(x2) (3.4)

    for all x1,x2U. Replacing x2 by x2 in (3.4), using the oddness of g and again adding the resultant to (3.4), we get

    f(2x1+x2)+f(2x1x2)=2f(x1+x2)+2f(x1x2) (3.5)

    for all x1,x2U. Replacing (x1,x2) by (x1+x2,x1x2) in (3.5), we get

    f(3x1+x2)+f(x1+3x2)=4f(x1)+4f(x2) (3.6)

    for all x1,x2U. Replacing x1 by x2 and x2 by x1 in (3.4), we have

    f(2x1+x2)+f(x1+2x2)=4f(x1+x2)f(x1)f(x2) (3.7)

    for all x1,x2U. Replacing (x1,x2) by (x1,x1+x2) in (3.4), we get

    f(3x1+x2)2f(2x1+x2)=f(x1+x2) (3.8)

    for all x1,x2U. Replacing x1 by x2 and x2 by x1 in (3.8) and adding the resultant equation to (3.8), we obtain

    f(3x1+x2)+f(x1+3x2)2f(2x1+x2)2f(x1+2x2)=2f(x1+x2) (3.9)

    for all x1,x2U. Using (3.6), (3.7) and (3.9), we obtain (1.1). Hence the mapping f is additive.

    In this section, we prove the Ulam stability of the n-variablel mixed type functional equation (1.3) for even case in probabilistic modular spaces (PM-spaces) by using fixed point technique.

    For a mapping f:M(V,μ), consider

    Se(x,y)=n1i=1,j=i+1(f(2xi+xj))+f(2xn+x1)2[n1i=1,j=i+1(f(xi+xj))+f(xn+x1)]ni=1f(xi)

    for nN.

    Theorem 4.1. Let M be a linear space and (V,μ) be a μ-complete b-homogeneous PM-space. Suppose that a mapping f:M(V,μ) satisfies an inequality

    μ(Se(x1,x2,,xn))ρ(x1,x2,,xn)(t) (4.1)

    for all x1,x2,,xnM and a given mapping ρ:M×MΔ such that

    ρ(2ax,0,,0)(22baNt)ρ(x,0,,0)(t) (4.2)

    for all xM and

    ρ(2amx1,2amx2,,2amxn)(22bamt)=1 (4.3)

    for all x1,x2,,xnM and a constant 0<N<12b. Then there exists a unique quadratic mapping T:M(V,μ) satisfying (2.1) and

    μ(T(x)f(x))(t22bNa12(12bN))ρ(x,0,,0)(t) (4.4)

    for all xM.

    Proof. Replacing (x1,x2,,xn) by (x,0,,0) in (4.1), we obtain

    μ(f(2x)22f(x))(t)ρ(x,0,,0)(t) (4.5)

    for all xM. This implies

    μ(f(2x)22f(x))(t)=μ(f(2x)22f(x))(22bt)ρ(x,0,,0)(22bt) (4.6)

    for all xM. Replacing x by 21x in (4.6), we obtain

    μ(f(21x)22f(x))(t)=μ(f(x)22f(21x))(t22b)ρ(21x,0,,0)(22bN1Nt22b)ρ(x,0,,0)(22bN1t). (4.7)

    From (4.6) and (4.7), we obtain

    μ(f(2ax)22af(x))(t)Ψ(x)(t):=ρ(x,0,,0)(22bNa12t) (4.8)

    for all xM.

    Consider P:={f:M(U,μ)|f(0)=0} and define η on P as follows:

    η(f)=inf{l>0:μ(f(x))(lt)Ψ(x)(t),xM}.

    It is simple to prove that η is modular on N and indulges the Δ2-condition with 2b=κ and Fatou property. Also, N is η-complete (see [25]). Consider the mapping Q:PηPη defined by QT(x):=T(2ax)22a for all TPη.

    Let f,jPη and l>0 be an arbitrary constant with η(fj)l. From the definition of η, we get

    μ(f(x)j(x))(lt)Ψ(x)(t)

    for all xM. This implies

    μ(Qf(x)Qj(x))(Nlt)=μ(22af(2ax)22aj(2ax))(Nlt)=μ(f(2ax)j(2ax))(22baNlt)Ψ(2ax)(22baNt)Ψ(x)(t)

    for all xM. Hence η(QfQj)Nη(fj) for all f,jPη, which means that Q is an η-strict contraction. Replacing x by 2ax in (4.8), we have

    μ(f(22ax)22af(2ax))(t)Ψ(2ax)(t) (4.9)

    for all xM and therefore

    μ(22(2a)f(22ax)22af(2ax))(Nt)=μ(22af(22ax)f(2ax))(22baNt)Ψ(2ax)(22baNt)Ψ(x)(t) (4.10)

    for all xE. Now

    μ(f(22ax)22(2a)f(x))(2b(Nt+t))μ(f(22ax)22(2a)f(2ax)22a)(Nt)μ(f(2ax)22af(x))(t)Ψ(x)(t) (4.11)

    for all xM. In (4.11), replacing x by 2ax and 2b(Nt+t) by 22βa2b(N2t+Nt), we obtain

    μ(f(23ax)22(2a)f(2ax))(22ba2b(N2t+Nt))Ψ(2ax)(22bjNt)Ψ(x)(t) (4.12)

    for all xM. Therefore,

    μ(f(23ax)23(2a)f(2ax)22a)(2b(N2t+Nt))Ψ(x)(t) (4.13)

    for all xM. This implies

    μ(f(23ax)23(2a)f(x))(2b(2b(N2t+Nt)+t))μ(f(23ax)23(2a)f(2ax)22a)(2b(N2t+Nt))μ(f(2ax)22af(x))(t)Ψ(x)(t) (4.14)

    for all xM. Generalizing the above inequality, we get

    μ(f(2amx)22(am)f(x))((2bN)m1t+2bm1i=1(2bN)i1t)Ψ(x)(t) (4.15)

    for all xM and a positive integer m. Hence we have

    η(Qmff)(2bN)m1+2bm1i=1(2bN)i12bmi=1(2bN)i12b12bN. (4.16)

    Now, one can easily prove that {Qm(f)} is ηconverges to TPη (see [25]). Thus (4.16) becomes

    η(Tf)2b12bN, (4.17)

    which implies

    μ(T(x)f(x))(2b12bNt)Ψ(x)(t)=ρ(x,0,,0)(2b22bNa12t) (4.18)

    for all xM and hence we have

    μ(T(x)f(x))(t22bNa12(12bN))ρ(x,0,,0)(t) (4.19)

    for all xM and hence the inequality (4.4) holds. One can easily prove the uniqueness of T (see [25]).

    In this section, we prove the Ulam stability of the n-variable mixed type functional equation (1.3) for odd case in probabilistic modular spaces (PM-spaces) by using fixed point technique.

    For a mapping f:M(U,μ), consider

    So(x1,x2,,xn)=n1i=1,j=i+1(f(2xi+xj))+f(2xn+x1)2[n1i=1,j=i+1(f(xi+xj))+f(xn+x1)]+ni=1f(xi)

    for nN.

    Theorem 5.1. Let M be a linear space and (V,μ) be a μ-complete b-homogeneous PM-space. Suppose that a mapping f:M(V,μ) satisfies an inequality

    μ(So(x1,x2,,xn))ρ(x1,x2,,xn)(t) (5.1)

    for all x1,x2,,xnM and a given mapping ρ:M×MΔ such that

    ρ(2ax,0,,0)(2baNt)ρ(x,0,,0)(t) (5.2)

    for all xM and

    ρ(2amx1,2amx2,,2amxn)(2bamt)=1 (5.3)

    for all x1,x2,,xnM and a constant 0<N<12b. Then there exists a unique additive mapping A:M(V,μ) satisfying (3.1) and

    μ(A(x)f(x))(t2bNa12(12bN))ρ(x,0,,0)(t) (5.4)

    for all xM.

    Proof. Replacing (x1,x2,,xn) by (x,0,,0) in (5.1), we obtain

    μ(f(2x)2f(x))(t)ρ(x,0,,0)(t) (5.5)

    for all xM. This implies

    μ(f(2x)2f(x))(t)=μ(f(2x)2f(x))(2bt)ρ(x,0,,0)(2bt) (5.6)

    for all xM. Replacing x by 21x in (5.6), we obtain

    μ(f(21x)21f(x))(t)=μ(f(x)2f(21x))(t2b)ρ(21x,0,,0)(2bN1Nt2b)ρ(x,0,,0)(2bN1t). (5.7)

    From (5.6) and (5.7), we obtain

    μ(f(2ax)2af(x))(t)Ψ(x)(t):=ρ(x,0,,0)(2bNa12t) (5.8)

    for all xM.

    Consider P:={f:M(U,μ)|f(0)=0} and define η on P as follows:

    η(f)=inf{l>0:μ(f(x))(lt)Ψ(x)(t),xM}.

    It is simple to prove that η is modular on N and indulges the Δ2-condition with 2b=κ and Fatou property. Also, N is η-complete (see [25]). Consider a mapping Q:PηPη defined by QA(x):=A(2ax)2a for all APη.

    Let f,jPη and l>0 be an arbitrary constant with η(fj)l. From the definition of η, we get

    μ(f(x)j(x))(lt)Ψ(x)(t)

    for all xM. This implies

    μ(Qf(x)Qj(x))(Nlt)=μ(2af(2ax)2aj(2ax))(Nlt)=μ(f(2ax)j(2ax))(2baNlt)Ψ(2ax)(2baNt)Ψ(x)(t)

    for all xM. Hence η(QfQj)Nη(fj) for all f,jPη, which means that Q is an η-strict contraction. Replacing x by 2ax in (5.8), we get

    μ(f(22ax)2af(2ax))(t)Ψ(2ax)(t) (5.9)

    for all xM and thus

    μ(22af(22ax)2af(2ax))(Nt)=μ(2af(22ax)f(2ax))(2baNt)Ψ(2ax)(2baNt)Ψ(x)(t), (5.10)

    for all xE. Now

    μ(f(22ax)22af(x))(2b(Nt+t))μ(f(22ax)22af(2ax)2a)(Nt)μ(f(2ax)2af(x))(t)Ψ(x)(t) (5.11)

    for all xM. In (5.11), replacing x by 2ax and 2b(Nt+t) by 2ba2b(N2t+Nt), we obtain

    μ(f(23ax)22af(2ax))(2ba2b(N2t+Nt))Ψ(2ax)(2bjNt)Ψ(x)(t) (5.12)

    for all xM. Therefore,

    μ(f(23ax)23af(2ax)2a)(2b(N2t+Nt))Ψ(x)(t) (5.13)

    for all xM. This implies

    μ(f(23ax)23af(x))(2b(2b(N2t+Nt)+t))μ(f(23ax)23af(2ax)2a)(2b(N2t+Nt))μ(f(2ax)2af(x))(t)Ψ(x)(t) (5.14)

    for all xM. Generalizing the above inequality, we have

    μ(f(2amx)2amf(x))((2bN)m1t+2bm1i=1(2bN)i1t)Ψ(x)(t) (5.15)

    for all xM and a positive integer m. Hence we have

    η(Qmff)(2bN)m1+2bm1i=1(2bN)i12bmi=1(2bN)i12b12bN. (5.16)

    Now, one can easily prove that {Qm(f)} is η-convergent to APη (see [25]). Thus (4.16) becomes

    η(Af)2b12bN, (5.17)

    which leads

    μ(A(x)f(x))(2b12bNt)Ψ(x)(t)=ρ(x,0,,0)(2b2bNa12t) (5.18)

    for all xM and hence we have

    μ(A(x)f(x))(t2bNa12(12bN))ρ(x,0,,0)(t) (5.19)

    for all xM and hence the inequality (5.4) holds. One can easily prove the uniqueness of A (see [25]).

    In this paper, we introduced a new n-variable mixed type functional equation satisfied by the solution f(x)=ax+bx2. Mainly, we obtained its general solution and investigated its Ulam stability in PM-spaces by using fixed point theory and we hope that this research work is a further improvement in the field of functional equations.

    This work was supported by Incheon National University Research Grant 2020-2021.

    The authors equally conceived of the study, participated in its design and coordination, drafted the manuscript, participated in the sequence alignment, and read and approved the final manuscript.

    The authors declare that they have no competing interests.



    Conflicts of interest



    The author declares there is no conflicts of interest.

    [1] Golden DBK (2017) Anaphylaxis: recognizing risk and targeting treatment. J Allergy Clin Immunol Pract 5: 1224-1226. doi: 10.1016/j.jaip.2017.06.028
    [2] Sienra-Monge JL, Navarrete-Rodriguez EM, Chavez-Flores U, et al. (2019) Anaphylaxis in children and adults: prevention, diagnosis and treatment. Rev Conamed 24: 107-164. [Article in Spanish].
    [3] Alvarez-Perea A, Ameiro B, Morales C, et al. (2017) Anaphylaxis in the pediatric emergency department: analysis of 133 cases after an allergy workup. J Allergy Clin Immunol Pract 5: 1256-1263. doi: 10.1016/j.jaip.2017.02.011
    [4] Wood RA, Camargo CA, Lieberman P, et al. (2014) Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Imunol 133: 461-467. doi: 10.1016/j.jaci.2013.08.016
    [5] Ma L, Danoff TM, Borish L (2014) Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 133: 1075-1083. doi: 10.1016/j.jaci.2013.10.029
    [6] Turner PJ, Jerschow E, Umasunthar T, et al. (2017) Fatal anaphylaxis: mortality rate and risk factors. J Allergy Clin Immunol Pract 5: 1169-1178. doi: 10.1016/j.jaip.2017.06.031
    [7] Greenberger P, Rotskoff BD, Lifschvitz B (2007) Fatal anaphylaxis: post-mortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 98: 252-257. doi: 10.1016/S1081-1206(10)60714-4
    [8] Pumphrey RS (2004) Fatal anaphylaxis in the UK: 1992–2001. Novartis Found Symp 257: 116-128.
    [9] Yunginger JW, Nelson DR, Squillace DL, et al. (1991) Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci 36: 857-865. doi: 10.1520/JFS13095J
    [10] Pumphrey RS (2000) Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 30: 1144-1150. doi: 10.1046/j.1365-2222.2000.00864.x
    [11] Campbell RL, Li JTC, Nicklas RA, et al. (2014) Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol 113: 599-608. doi: 10.1016/j.anai.2014.10.007
    [12] Bonds RS, Asawa A, Ghazi AI (2015) Misuse of medical devices: a persistent problem in self-management of asthma and allergic disease. Ann Allergy Asthma Immunol 114: 74-76. doi: 10.1016/j.anai.2014.10.016
    [13] Ridolo E, Montagni M, Bonzano L, et al. (2015) How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients. Intern Emerg Med 10: 937-941. doi: 10.1007/s11739-015-1255-z
    [14] Ewan P, Braithwaite N, Leech S, et al. (2016) BSACI guideline: prescribing an adrenaline auto-injector. Clin Exp Allergy 46: 1258-1280. doi: 10.1111/cea.12788
    [15] Mehr S, Robinson M, Tang M (2007) Doctor—How do I use my EpiPen? Pediatr Allergy Immunol 18: 448-452. doi: 10.1111/j.1399-3038.2007.00529.x
    [16] Saleh-Vandenberg J, deVries S, Bak E, et al. (2017) Incomplete and incorrect epinephrine auto-injector training to food allergic patients by pharmacists in the Netherlands. Pediatr Allergy Immunol 28: 238-244. doi: 10.1111/pai.12688
    [17] Salter SM, Loh R, Sanfilippo F, et al. (2014) Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement. Allergy Asthma Clin Immunol 10: 49. doi: 10.1186/1710-1492-10-49
    [18] Mahoney B, Walklet E, Bradley E, et al. (2019) Improving adrenaline autoinjector adherence: a psychologically informed training for healthcare professionals. Immun Inflamm Dis 7: 214-228. doi: 10.1002/iid3.264
    [19] Antiñolo FMG (2015) How incorrect is the use of adrenaline auto-injectors? Intern Emerg Med 10: 887-888. doi: 10.1007/s11739-015-1290-9
    [20] Waserman S, Avilla E, Ben-Shoshan M, et al. (2017) Epinephrine autoinjectors: new data, new problems. J Allergy Clin Immunol Pract 5: 1180-1191. doi: 10.1016/j.jaip.2017.06.027
    [21] Brown AFT (2009) Current management of anaphylaxis. Emergencias 21: 213-223.
    [22] García-Magán C, Montero JMG, Moure-González JD, et al. (2020) Rapid and safe use of adrenaline auto-injectors: We have a problem!. An Pediatr (Barc) 92: 388-389. [Article in Spanish]. doi: 10.1016/j.anpedi.2019.11.006
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(3019) PDF downloads(103) Cited by(0)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog